This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Tolerability of Antipsychotics: Recent Controversies and Future Management

W. Wolfgang Fleischhacker

Published: March 16, 2009

This CME activity is expired. For more CME activities, visit
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Article Abstract

Individuals with schizophrenia experience increased morbidity and mortality due to both natural and unnatural causes. Some antipsychotics used to treat this disorder may contribute to the poor physical health in this population. Clinicians must accept responsibility for both the physical and mental health care of patients with schizophrenia by preferentially selecting antipsychotics with a low incidence of adverse side effects, monitoring for any metabolic disturbances that may be associated with these drugs, and actively managing risk factors that may worsen patients’ physical health.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: